CXCL8 and neoplasm: The finding that IFNγ inhibits the secretion of CXCL8 in BCPAP cells prompted us to evaluate whether cell migration, a well characterized CXCL8 mediated tumor-promoting activity [9, 11], was also affected by IFNγ treatment.